Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Dami&Xiaomi

Explore full profile

A professional service platform for children with autism spectrum and pervasive developmental disabilities, providing integrated services such as rehabilitation intervention, integration support, home…

Shenzhen, ChinaFounded 2014Health Tech & Medtech
Valuation $250–500M Last recorded · 2022
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Dami&Xiaomi and the history behind them.

About Dami&Xiaomi

Dami&Xiaomi, registered as Shenzhen Fumi Health Technology Co., Ltd., is a specialized service platform in China focused on children with autism spectrum disorder and other developmental disabilities. The company was established in September 2014 by Jiang Yingshuang, a former chief reporter for Southern Metropolis Daily. Her journey into this field began after her own daughter was mistakenly diagnosed with autism, leading her to identify a critical need for structured, scientific support for affected families in China.

The firm primarily serves families of children aged 1 to 12 who experience challenges such as autism, social and language delays, and learning difficulties. Its business model integrates online and offline services. Revenue is generated through its network of physical rehabilitation centers, which offer one-on-one and group intervention sessions, as well as through online consultations, parent training programs, and a proprietary mobile application. Since opening its first center in Shenzhen in 2016, Dami&Xiaomi has expanded to operate over 50 centers across major Chinese cities, including Beijing, Shanghai, and Guangzhou, serving thousands of children.

A key offering is the RICE Social Ladder Rehabilitation System, an intervention framework with its own intellectual property rights, developed in 2019. This system provides a comprehensive approach that includes assessment, individualized education plans (IESP), and dynamic feedback. It focuses on improving core social and communication skills, incorporating intensive behavioral intervention, language rehabilitation, and sensory integration training. In 2025, the company partnered with Tencent SSV to launch an AI-powered advisory tool to provide guidance to parents and therapists. The company has successfully raised significant capital through multiple funding rounds, including a $42 million Series D in July 2022, to fuel its expansion and technology development.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Shenzhen, China
Employees
4
Open positions
None listed
Dealroom signal
25.7/100
Industry
Health, Kids
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Disability tech, Hard Tech
Business model
SaaS
Client focus
b2c

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Jul 2022 $42M $168M OrbiMed · Grand Flight Investment · YuanBio Venture Capital · ABC Impact ↗
SERIES COther financing Nov 2020 $1.5M $6.1M OrbiMed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Dami&Xiaomi website traffic

Latest recorded traffic for Dami&Xiaomi is 100 monthly website visits, up 0% over the last three months. Dami&Xiaomi's team grew 0% over the past year.

Latest monthly visits100 3-month web change0% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Fortune Capital
  • Yuansheng BioVenture

Series B and later4 investors entered at this stage

  • OrbiMed
  • ABC Impact
  • Grand Flight Investment
  • YuanBio Venture Capital
Employees 4 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Dami&Xiaomi on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dami&Xiaomi’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.